Propanc Biopharma (PPCB) shares were more than 151% higher pre-bell Monday, reversing from a 28% drop in the previous session.
BioXcel Therapeutics (BTAI) stock was up 29% after the company said it received positive comments from the US Food and Drug Administration regarding the company's planned supplemental new drug application submission for BXCL501 in agitation associated with bipolar disorders or schizophrenia.
Dayforce (DAY) shares were 26% higher following a media report that the company is being considered for takeover by Thoma Bravo.
Xunlei (XNET) stock was up 17%, extending Friday's rally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.